Scholars Central

Review articlePublished 11 Jul 2012

Potential Cardiometabolic Benefits of Renal Artery Denervation in Diabetics

Authors: Suraj Maraj, Rikesh Patel, Rene Oliveros, Saurabh Sanon, Tim Dao, Sik Hur, Robert Chilton

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Treatment of hypertension using renal artery sympathetic denervation was first reported as early as 1924, [1] but only recently has the advent of safer, less invasive techniques allowed this treatment modality to emerge as a promising treatment for hypertension [2-4]. Aside from reductions in blood pressure, the effect of this treatment appears to be more widespread than initially thought. Renal artery sympathetic denervation may globally reduce cardiovascular risk through a variety of mechanisms such as decreased insulin resistance, oxidative stress, and organ hypertrophy, along with improvement in diastolic function and other metabolic parameters [5-11]. The following is a comprehensive review of current literature on renal artery sympathetic denervation with a focus on potential cardiovascular benefits.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectCardiology
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Suraj Maraj”
  • BylineArticles whose byline prints “Rikesh Patel”
  • BylineArticles whose byline prints “Rene Oliveros”
  • BylineArticles whose byline prints “Saurabh Sanon”
  • BylineArticles whose byline prints “Tim Dao”
  • BylineArticles whose byline prints “Sik Hur”
  • BylineArticles whose byline prints “Robert Chilton”